Description
Fifteen years ago, the Asia-Pacific (APAC) region offered new arenas for pharmaceutical companies to implement Medical Affairs functions. Even just a few years ago, the Asia-Pacific Medical Science Liaisons function was still in its initial stages of development. Now, however, it has grown into a more formal function that has adapted to the markets and has been adopted by Thought Leaders’ and Physicians’ communities. For a region that barely had a need for medical affairs operations, companies realized this function becoming a key element for successfully establishing brands.
Arx Research conducted a study of the medical liaison function in Asia-Pacific to uncover and present findings and KPIs on:
-Organizational Structures
-MSL Team Staffing
-Key Metrics
-Thought Leader Management
-MSL Profiles
-Budget Metrics
-Seven (7) MSL Team Profiles
The study delivers findings to help medical affairs personnel – from management to scientific field operatives – support their decisions to assess their operation, refine their strategy and strengthen their engagements to thought leaders.
The Asia-Pacific Medical Science Liaisons report findings are based on exchanges with 23 Asia-Pacific-based executives and MSLs representing 21 companies located in 12 countries.
Similar analytical research on medical science liaison operations also available for Africa, Europe, Central/South America and North America. Additional in-depth research on MSL training and performance metrics also available here: https://www.arxresearch.com/product-category/medical-affairs/\